GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lianluo Smart Ltd (NAS:LLIT) » Definitions » COGS-to-Revenue

Lianluo Smart (Lianluo Smart) COGS-to-Revenue : 3.47 (As of Dec. 2020)


View and export this data going back to 2010. Start your Free Trial

What is Lianluo Smart COGS-to-Revenue?

Lianluo Smart's Cost of Goods Sold for the six months ended in Dec. 2020 was $0.07 Mil. Its Revenue for the six months ended in Dec. 2020 was $0.02 Mil.

Lianluo Smart's COGS to Revenue for the six months ended in Dec. 2020 was 3.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Lianluo Smart's Gross Margin % for the six months ended in Dec. 2020 was -247.37%.


Lianluo Smart COGS-to-Revenue Historical Data

The historical data trend for Lianluo Smart's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lianluo Smart COGS-to-Revenue Chart

Lianluo Smart Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.88 1.36 1.94 1.80

Lianluo Smart Semi-Annual Data
Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.73 2.30 1.71 3.47

Lianluo Smart COGS-to-Revenue Calculation

Lianluo Smart's COGS to Revenue for the fiscal year that ended in Dec. 2020 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.647 / 0.359
=1.80

Lianluo Smart's COGS to Revenue for the quarter that ended in Dec. 2020 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.066 / 0.019
=3.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lianluo Smart  (NAS:LLIT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Lianluo Smart's Gross Margin % for the six months ended in Dec. 2020 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.066 / 0.019
=-247.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Lianluo Smart COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lianluo Smart's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lianluo Smart (Lianluo Smart) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Roa, Room 611, 6th Floor, BeiKong Technology Building, Changping District, Beijing, CHN, 102200
Lianluo Smart Ltd design, develop and market medical products and medical components. The company focuses on the business sectors of; Medical Equipment and the provision of Obstructive Sleep Apnea Syndrome (OSAS) diagnostic services. Its products include wearable sleep respiratory devices, medical devices for cardiopulmonary resuscitation, DHR998 Plus, and others. The company sells its products to distributors, hospitals and physical examination centers, and others. All of its revenue is generated from China.